<s id="wsj_1904.1"> 35
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Britain 's
2 	 1 	 (NP[nb]/N)\NP 	 1 	 Monopolies 's
2 	 7 	 (S[dcl]\NP)/NP 	 1 	 Monopolies cleared
2 	 21 	 (S[ng]\NP)/S[dcl] 	 1 	 Monopolies saying <XB>
5 	 1 	 (NP[nb]/N)\NP 	 1 	 Commission 's
5 	 4 	 N/N 	 1 	 Commission Mergers
5 	 7 	 (S[dcl]\NP)/NP 	 1 	 Commission cleared
5 	 21 	 (S[ng]\NP)/S[dcl] 	 1 	 Commission saying <XB>
7 	 6 	 (S\NP)/(S\NP) 	 2 	 cleared Wednesday
9 	 8 	 N/N 	 1 	 S.A. Rhone-Poulenc
9 	 10 	 (NP[nb]/N)\NP 	 2 	 S.A. 's
11 	 7 	 (S[dcl]\NP)/NP 	 2 	 purchase cleared
11 	 10 	 (NP[nb]/N)\NP 	 1 	 purchase 's
11 	 12 	 (NP\NP)/NP 	 1 	 purchase of
11 	 17 	 (NP\NP)/NP 	 1 	 purchase from
16 	 12 	 (NP\NP)/NP 	 2 	 unit of
16 	 13 	 NP[nb]/N 	 1 	 unit a
16 	 14 	 N/N 	 1 	 unit specialty
16 	 15 	 N/N 	 1 	 unit bulk-chemical
19 	 17 	 (NP\NP)/NP 	 2 	 Co. from
19 	 18 	 N/N 	 1 	 Co. Monsanto
23 	 22 	 NP[nb]/N 	 1 	 purchase the
23 	 24 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 purchase was
23 	 25 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 purchase unlikely <XB>
24 	 21 	 (S[ng]\NP)/S[dcl] 	 2 	 was saying
25 	 24 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 unlikely was
26 	 25 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to unlikely
27 	 26 	 (S[to]\NP)/(S[b]\NP) 	 2 	 have to
30 	 27 	 (S[b]\NP)/NP 	 2 	 impact have
30 	 28 	 NP[nb]/N 	 1 	 impact any
30 	 29 	 N/N 	 1 	 impact lasting
30 	 31 	 (NP\NP)/NP 	 1 	 impact on
34 	 31 	 (NP\NP)/NP 	 2 	 consumers on
34 	 32 	 N/N 	 1 	 consumers U.K.
34 	 33 	 N/N 	 1 	 consumers industrial
<\s>
<s id="wsj_1904.2"> 52
1 	 0 	 NP[nb]/N 	 1 	 commission The
1 	 3 	 (NP\NP)/(S[dcl]\NP) 	 1 	 commission which
1 	 4 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 commission was <XB>
1 	 5 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 commission asked <XB>
1 	 7 	 (S[b]\NP)/NP 	 1 	 commission study <XB>
1 	 23 	 (S[dcl]\NP)/S[dcl] 	 1 	 commission said
4 	 3 	 (NP\NP)/(S[dcl]\NP) 	 2 	 was which
5 	 4 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 asked was
5 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 asked by
5 	 17 	 ((S\NP)\(S\NP))/NP 	 2 	 asked after
6 	 5 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to asked
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 study to
9 	 7 	 (S[b]\NP)/NP 	 2 	 deal study
9 	 8 	 NP[nb]/N 	 1 	 deal the
12 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 Department by
12 	 11 	 NP[nb]/N 	 1 	 Department the
12 	 13 	 (NP\NP)/NP 	 1 	 Department of
14 	 13 	 (NP\NP)/NP 	 2 	 Trade of
16 	 13 	 (NP\NP)/NP 	 2 	 Industry of
19 	 17 	 ((S\NP)\(S\NP))/NP 	 3 	 announcement after
19 	 18 	 NP[nb]/N 	 1 	 announcement its
19 	 20 	 (NP\NP)/NP 	 1 	 announcement in
21 	 20 	 (NP\NP)/NP 	 2 	 February in
25 	 24 	 NP[nb]/N 	 1 	 diversity the
25 	 26 	 (NP\NP)/NP 	 1 	 diversity of
25 	 36 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 diversity was
25 	 37 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 diversity great <XB>
28 	 26 	 (NP\NP)/NP 	 2 	 supply of
28 	 27 	 N/N 	 1 	 supply global
28 	 29 	 (NP\NP)/NP 	 1 	 supply of
30 	 29 	 (NP\NP)/NP 	 2 	 chemicals of
30 	 31 	 S[pss]\NP 	 1 	 chemicals used <XB>
30 	 33 	 (S[ng]\NP)/NP 	 1 	 chemicals making <XB>
31 	 32 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 used in
33 	 32 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 making in
35 	 33 	 (S[ng]\NP)/NP 	 2 	 drugs making
35 	 34 	 N/N 	 1 	 drugs analgesic
36 	 23 	 (S[dcl]\NP)/S[dcl] 	 2 	 was said
37 	 36 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 great was
37 	 38 	 (S[adj]\NP)\(S[adj]\NP) 	 2 	 great enough
39 	 37 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to great
40 	 39 	 (S[to]\NP)/(S[b]\NP) 	 2 	 offset to
45 	 40 	 (S[b]\NP)/NP 	 2 	 share offset
45 	 41 	 NP[nb]/N 	 1 	 share the
45 	 42 	 N/N 	 1 	 share dominant
45 	 43 	 N/N 	 1 	 share U.K.
45 	 44 	 N/N 	 1 	 share market
45 	 48 	 (S[b]\NP)/NP 	 2 	 share gain <XU>
46 	 47 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Rhone-Poulenc would
46 	 48 	 (S[b]\NP)/NP 	 1 	 Rhone-Poulenc gain <XB>
48 	 47 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 gain would
48 	 49 	 ((S\NP)\(S\NP))/NP 	 2 	 gain through
51 	 49 	 ((S\NP)\(S\NP))/NP 	 3 	 acquisition through
51 	 50 	 NP[nb]/N 	 1 	 acquisition the
<\s>
<s id="wsj_1904.3"> 23
3 	 0 	 NP[nb]/N 	 1 	 giant The
3 	 1 	 N/N 	 1 	 giant French
3 	 2 	 N/N 	 1 	 giant chemical
3 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 giant would
3 	 5 	 (S[b]\NP)/NP 	 1 	 giant hold <XB>
5 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 hold would
8 	 7 	 (N/N)/(N/N) 	 2 	 % 80
9 	 5 	 (S[b]\NP)/NP 	 2 	 share hold
9 	 6 	 NP[nb]/N 	 1 	 share an
9 	 8 	 N/N 	 1 	 share %
9 	 10 	 (NP\NP)/NP 	 1 	 share of
13 	 10 	 (NP\NP)/NP 	 2 	 market of
13 	 11 	 NP[nb]/N 	 1 	 market the
13 	 12 	 N/N 	 1 	 market U.K.
13 	 14 	 (NP\NP)/NP 	 1 	 market for
16 	 14 	 (NP\NP)/NP 	 2 	 acid for
16 	 15 	 N/N 	 1 	 acid salicylic
19 	 14 	 (NP\NP)/NP 	 2 	 salicylate for
19 	 18 	 N/N 	 1 	 salicylate methyl
22 	 14 	 (NP\NP)/NP 	 2 	 aspirin for
22 	 21 	 N/N 	 1 	 aspirin bulk
<\s>
<s id="wsj_1904.4"> 34
1 	 0 	 NP[nb]/N 	 1 	 commission The
1 	 2 	 (S[dcl]\NP)/S[em] 	 1 	 commission found
3 	 2 	 (S[dcl]\NP)/S[em] 	 2 	 that found
7 	 5 	 NP[nb]/N 	 1 	 government the
7 	 6 	 N/N 	 1 	 government British
7 	 8 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 government attempted
7 	 10 	 (S[b]\NP)/NP 	 1 	 government block <XB>
8 	 4 	 (S/S)/S[dcl] 	 2 	 attempted if
9 	 8 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to attempted
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 block to
12 	 10 	 (S[b]\NP)/NP 	 2 	 merger block
12 	 11 	 NP[nb]/N 	 1 	 merger the
14 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Rhone-Poulenc would
14 	 17 	 S[b]\NP 	 1 	 Rhone-Poulenc respond <XB>
14 	 19 	 (S[ng]\NP)/NP 	 1 	 Rhone-Poulenc closing <XB>
14 	 28 	 (S[ng]\NP)/NP 	 1 	 Rhone-Poulenc removing <XB>
15 	 3 	 S[em]/S[dcl] 	 1 	 would that
15 	 4 	 (S/S)/S[dcl] 	 1 	 would if
15 	 16 	 (S\NP)\(S\NP) 	 2 	 would likely
17 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 respond would
17 	 18 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 respond by
19 	 18 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 closing by
22 	 19 	 (S[ng]\NP)/NP 	 2 	 plant closing
22 	 20 	 NP[nb]/N 	 1 	 plant the
22 	 21 	 N/N 	 1 	 plant salicylates
22 	 24 	 (S[dcl]\NP)/NP 	 2 	 plant operates <XU>
22 	 25 	 (NP\NP)/NP 	 1 	 plant in
23 	 24 	 (S[dcl]\NP)/NP 	 1 	 Monsanto operates
26 	 25 	 (NP\NP)/NP 	 2 	 Wales in
28 	 31 	 ((S\NP)\(S\NP))/NP 	 2 	 removing from
30 	 28 	 (S[ng]\NP)/NP 	 2 	 matter removing
30 	 29 	 NP[nb]/N 	 1 	 matter the
33 	 31 	 ((S\NP)\(S\NP))/NP 	 3 	 jurisdiction from
33 	 32 	 N/N 	 1 	 jurisdiction U.K.
<\s>
